With 0.52 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.85 million shares. The 52-week range on UTI shows that it touched its highest point at $36.32 and its lowest point at $13.66 during that stretch. It currently has a 1-year price target of $37.43. Beta for the stock currently stands at 1.61.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UTI was down-trending over the past week, with a drop of -8.39%, but this was down by -4.39% over a month. Three-month performance surged to 21.29% while six-month performance rose 27.40%. The stock gained 126.51% in the past year, while it has gained 26.95% so far this year. A look at the trailing 12-month EPS for UTI yields 1.04 with Next year EPS estimates of 1.07. For the next quarter, that number is 0.11. This implies an EPS growth rate of 39.43% for this year and 1.91% for next year.
Float and Shares Shorts:
At present, 54.41 million UTI shares are outstanding with a float of 50.27 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UTI since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.71548 being high and $0.69835 being low. For UTI, this leads to a yearly average estimate of $0.70833.
